Insufficient scRNA-seq data for expression of HTN3 at single-cell level.
Insufficient scRNA-seq data for expression of HTN3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
eye | 0% | 0 | 0 / 0 | 29% | 32.55 | 23 / 80 |
adrenal gland | 14% | 1.71 | 36 / 258 | 15% | 4.34 | 34 / 230 |
skin | 0% | 0.01 | 2 / 1809 | 9% | 106.10 | 44 / 472 |
muscle | 6% | 0.79 | 49 / 803 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.04 | 9 / 459 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.04 | 6 / 430 |
lung | 1% | 0.03 | 4 / 578 | 1% | 0.01 | 8 / 1155 |
stomach | 1% | 0.03 | 2 / 359 | 1% | 0.01 | 2 / 286 |
breast | 1% | 0.05 | 3 / 459 | 1% | 0.02 | 6 / 1118 |
prostate | 1% | 0.03 | 2 / 245 | 0% | 0.03 | 1 / 502 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.09 | 4 / 504 |
brain | 1% | 0.08 | 15 / 2642 | 0% | 0 | 0 / 705 |
thymus | 0% | 0.05 | 3 / 653 | 0% | 0 | 0 / 605 |
spleen | 0% | 0.02 | 1 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 3 / 901 |
liver | 0% | 0 | 0 / 226 | 0% | 0.02 | 1 / 406 |
heart | 0% | 0.01 | 2 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.02 | 3 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.01 | 2 / 929 | 0% | 0 | 0 / 0 |
esophagus | 0% | 0.01 | 3 / 1445 | 0% | 0 | 0 / 183 |
intestine | 0% | 0.00 | 1 / 966 | 0% | 0 | 0 / 527 |
adipose | 0% | 0.00 | 1 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050832 | Biological process | defense response to fungus |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0031214 | Biological process | biomineral tissue development |
GO_0045087 | Biological process | innate immune response |
GO_0042742 | Biological process | defense response to bacterium |
GO_0005576 | Cellular component | extracellular region |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | HTN3 |
Protein name | Histatin-3 (Basic histidine-rich protein) (Hst) (Histatin 3) (Hst 3) (Histidine-rich protein 3) (PB) [Cleaved into: Histatin-3; His3-(20-44)-peptide (His3 20/44) (His3-(1-25)-peptide) (His3 1/25) (Histatin 6) (Histatin-3 1/25) (Histatin-6); His3-(20-43)-peptide (His3 20/43) (His3-(1-24)-peptide) (His3 1/24) (Histatin 5) (Hst 5) (Histatin-3 1/24) (Histatin-5); His3-(20-32)-peptide (His3 20/32) (His3-(1-13)-peptide) (His3 1/13) (Histatin-3 1/13); His3-(20-31)-peptide (His3 20/31) (His3-(1-12)-peptide) (His3 1/12) (Histatin-3 1/12); His3-(20-30)-peptide (His3 20/30) (His3-(1-11)-peptide) (His3 1/11) (Histatin-3 1/11); His3-(24-32)-peptide (His3 24/32) (His3-(5-13)-peptide) (His3 5/13) (Histatin-3 5/13); His3-(24-31)-peptide (His3 24/31) (His3-(5-12)-peptide) (His3 5/12) (Histatin 11) (Histatin-11) (Histatin-3 5/12); His3-(24-30)-peptide (His3 24/30) (His3-(5-11)-peptide) (His3 5/11) (Histatin 12) (Histatin-12) (Histatin-3 5/11); His3-(25-32)-peptide (His3 25/32) (His3-(6-13)-peptide) (His3 6/13) (Histatin-3 6/13); His3-(25-30)-peptide (His3 25/30) (His3-(6-11)-peptide) (His3 6/11) (Histatin-3 6/11); His3-(26-32)-peptide (His3 26/32) (His3-(7-13)-peptide) (His3 7/13) (Histatin-3 7/13); His3-(26-31)-peptide (His3 26/31) (His3-(7-12)-peptide) (His3 7/12) (Histatin-3 7/12); His3-(26-30)-peptide (His3 26/30) (His3-(7-11)-peptide) (His3 7/11) (Histatin-3 7/11); His3-(31-51)-peptide (His3 31/51) (His3-(12-32)-peptide) (His3 12/32) (Histatin 4) (Histatin-3 12/32) (Histatin-4); His3-(31-44)-peptide (His3 31/44) (His3-(12-25)-peptide) (His3 12/25) (Histatin 9) (Histatin-3 12/25) (Histatin-9); His3-(31-43)-peptide (His3 31/43) (His3-(12-24)-peptide) (His3 12/24) (Histatin 7) (Histatin-3 12/24) (Histatin-7); His3-(32-44)-peptide (His3 32/44) (His3-(13-25)-peptide) (His3 13/25) (Histatin 10) (Histatin-10) (Histatin-3 13/25); His3-(32-43)-peptide (His3 32-43) (His3-(13-24)-peptide) (His3 13/24) (Histatin 8) (Histatin-3 13/24) (Histatin-8); His3-(33-44)-peptide (His3 33/44) (His3-(14-25)-peptide) (His3 14/25) (Histatin-3 14/25); His3-(33-43)-peptide (His3 33/43) (His3-(14-24)-peptide) (His3 14/24) (Histatin-3 14/24); His3-(34-44)-peptide (His3 34/44) (His3-(15-25)-peptide) (His3 15/25) (Histatin-3 15/25); His3-(34-43)-peptide (His3 34/43) (His3-(15-24)-peptide) (His3 15/24) (Histatin-3 15/24); His3-(45-51)-peptide (His3 45/51) (His3-(26-32)-peptide) (His3 26/32) (Histatin-3 26/32); His3-(47-51)-peptide (His3 47/51) (His3-(28-32)-peptide) (His3 28/32) (Histatin-3 28/32); His3-(48-51)-peptide (His3 48/51) (His3-(29-32)-peptide) (His3 29/32) (Histatin-3 29/32)] Histatin-3 |
Synonyms | HIS2 |
Description | FUNCTION: Histatins are cationic and histidine-rich peptides mainly found in the saliva of higher primates . They are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). Hsts can be divided into two major groups according to their biological functions: antimicrobial Hsts (e.g. Hst 5/HTN3) and cell-activating Hsts (e.g. Hst 1/HTN1, Hst 2/HTN1 and Hst 3/HTN3) . .; FUNCTION: [Histatin-3]: Histatin 3 (Hst 3) is mostly involved in cell migration and wound healing in the oral cavity . Also stimulates cell proliferation after binding to heat shock protein HSC70, which enhances HSC70-CDKN1B complex formation and subsequent ubiquitination during G1/S transition . Also displays antifungal activity against pathogenic yeast Candida albicans, however with less effectiveness than Hst 5 . .; FUNCTION: [His3-(20-43)-peptide]: Histatin 5 (Hst 5), a fragment of Hst 3, is the major histatin exhibiting antifungal and antibacterial activities . It is effective against pathogenic yeast C. albicans, C. neoformans, C. glabrata and S. cerevisiae as well as ESKAPE bacterial pathogens . Secreted Hst 5 mediates a multi-step intracellular mechanism of action against the pathogen. Depending on peptide concentration and pathogen, uptake across the membrane can occur through transporters, direct interaction with plasma membrane and/or receptor-mediated endocytosis . Binds C. albicans cell wall proteins SSA1 and SSA2 and glycans in an energy-independent manner, then is taken up by the cells through fungal polyamine transporters DUR3 and DUR31 in an energy-dependent manner . Internalized Hst5 is then targeted to the energized mitochondrion to induce reactive oxygen species (ROS) formation and subsequent release of intracellular non-lytic ATP which ultimately leads to fungal cell death . In addition, inhibits C. albicans TRK1 potassium-transporter which causes exudation of intracellular K(+), generating an osmotic imbalance leading to delayed membrane lysis and cell death . Also acts as a potent inhibitor of bacterial proteases such as Lys-gingipain and Arg-gingipain (rgpB) from P. gingivalis as well as human metalloproteases MMP2 and MMP9 . The binding of metals such as zinc, copper or nickel with Hst 5 results in the protection of the enamel and antimicrobial activities such as the inhibition of microbial growth by decreasing the metal concentration, the formation of ROS commonly associated with redox-active metals, the induction of membrane disruption mediated by zinc binding . Also involved in coating oral surfaces in the form of a salivary film which reduces colonization by C. albicans on epithelial cell surfaces . Secreted Hst 5 can also internalize mammalian epithelial cells and target the mitochondria although it does not exert cytotoxic effects in these cells . In contrast with Hst 3, not able to promote wound healing in mammalian host cells . . |
Accessions | ENST00000635125.1 ENST00000635585.1 X6RAH8 ENST00000381057.3 ENST00000677679.1 ENST00000530128.5 ENST00000672568.1 P15516 ENST00000673563.1 |